본문 바로가기

pH-triggered surface charge-reversal nanoparticles alleviate experimental murine colitis via selective accumulation in inflamed colon regions

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
피인용
Web of Science 55Scopus 65
FWCI (Scopus)
1.68
JCR IF
JCR 2017 6.5
ISSN
1549-9634

저자

  1. 나임 무하마드제1저자College of Pharmacy, Pusan National University, Busan, South Korea
  2. 무타다 오시College of Pharmacy, Pusan National University, Busan, South Korea
  3. 김지현College of Pharmacy, Pusan National University, Busan, South Korea
  4. 이주호College of Pharmacy, Pusan National University, Busan, South Korea
  5. 차오쟈푸College of Pharmacy, Pusan National University, Busan, South Korea
  6. 핫산 눌하스니College of Pharmacy, Pusan National University, Busan, South Korea
  7. 임은옥College of Pharmacy, Pusan National University, Busan, South Korea
  8. 정연진College of Pharmacy, Pusan National University, Busan, South Korea
  9. 유진욱교신저자College of Pharmacy, Pusan National University, Busan, South Korea

초록

In this study, we developed pH-triggered surface charge-reversal lipid nanoparticles (LNPs), loaded with budesonide, which could precisely deliver the drug to inflamed colon segments for the treatment of ulcerative colitis. Polyethyleneimine (PEI) was used to render LNPs cationic (PEI-LNPs), and Eudragit (R) S100 (ES) was coated on PEI-LNPs to obtain pH-triggered charge-reversal LNPs (ES-PEI-LNPs). ES coating avoided a burst drug release under acidic conditions mimicking the stomach and early small intestine environments and showed a sustained release in the colon. The surface charge of ES-PEI-LNPs switched from negative to positive under colonic conditions owing to pH-triggered removal of the ES coating. Bioimaging of the mouse gastrointestinal tract and confocal analysis of colon tissues revealed that ES-PEI-LNPs selectively accumulated in an inflamed colon. Furthermore, ES-PEI-LNPs mitigated experimental colitis in mice. These results suggest that the pH-triggered charge-reversal LNPs could be a promising drug carrier for ulcerative colitis therapy and other colon-targeted treatments. (c) 2018 Elsevier Inc. All rights reserved.

키워드

Cationic lipid nanoparticlesStimuli-triggered charge-reversalUlcerative colitisMethacrylate copolymerBudesonideINFLAMMATORY-BOWEL-DISEASESOLID LIPID NANOPARTICLESTARGETED DRUG-DELIVERYN-TRIMETHYL CHITOSANORAL DELIVERYPOLYMERIC NANOPARTICLESCELLULAR UPTAKEMOUSE MODELSIN-VIVOBUDESONIDE

식별자

Scopus EID
2-s2.0-85041826620
WoS UID
000429528900018